News
A novel positive to negative voltage converter and a novel LDO regulator are proposed in this paper. Compared with the conventional voltage converter, the proposed one has a higher efficiency for a ...
Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies PR Newswire BOULDER, Colo., June 26, 2025 ...
CITY OF SAN FERNANDO, Pampanga (PIA)—A thousand minimum wage earners in Pampanga benefited from the pilot roll-out of the ‘Benteng Bigas, Meron Na!’ program in the province. Facilitated by the ...
Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 trials. Click for my updated look at SYRE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results